| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Revenue | 25.25B | 29.28B | 23.11B | 20.38B | 21.42B |
| Cost of Revenue | 13.54B | 18.46B | 13.05B | 10.48B | 11.79B |
| Gross Profit | 11.71B | 10.82B | 10.06B | 9.90B | 9.63B |
| Operating Expenses | 5.88B | 5.26B | 6.55B | 5.08B | 4.29B |
| Selling, General & Admin | 595.00M | 656.00M | 569.00M | 415.00M | 267.00M |
| Research & Development | N/A | N/A | N/A | N/A | N/A |
| Other Operating Expenses | 553.00M | 5.26B | 6.55B | 5.08B | 4.29B |
| Operating Income | 5.83B | 5.37B | 3.70B | 4.88B | 5.75B |
| Other Expenses / Income | 965.00M | -1.15B | -1.12B | -1.39B | 793.00M |
| Before Tax Income | 4.34B | 4.22B | 2.58B | 3.50B | 6.54B |
| Income Tax Expenses | 496.00M | 795.00M | 267.00M | 393.00M | 1.80B |
| Net Income | 3.98B | 3.54B | 2.41B | 3.13B | 4.75B |
| Interest Expenses | 2.45B | 2.02B | 1.84B | 1.82B | 1.74B |
| Basic Shares Outstanding | 1.09B | 1.07B | 1.06B | 1.10B | 1.05B |
| Diluted Shares Outstanding | 1.10B | 1.08B | 1.07B | 1.10B | 1.05B |
| EBITDA | 11.51B | 9.88B | 7.61B | 8.83B | 8.79B |
| EBITDA Margin | 45.57% | 33.74% | 32.93% | 43.32% | 41.02% |
| EBIT | 6.92B | 6.35B | 4.51B | 5.35B | 8.29B |
| EBIT Margin | 27.39% | 21.69% | 19.52% | 26.25% | 38.69% |
| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |